Status:
UNKNOWN
Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images
Lead Sponsor:
Chinese Academy of Sciences
Collaborating Sponsors:
Sun Yat-sen University
Guangdong Provincial People's Hospital
Conditions:
Nasopharyngeal Carcinoma
Image-Guided Biopsy
Eligibility:
All Genders
18+ years
Brief Summary
Due to the occult anatomic location of the nasopharynx and frequent presence of adenoid hyperplasia, the positive rate for nasopharyngeal carcinoma identification during biopsy is low, thus leading to...
Detailed Description
Due to the occult anatomic location of the nasopharynx and frequent presence of adenoid hyperplasia, the positive rate for nasopharyngeal carcinoma identification during biopsy is low, thus leading to...
Eligibility Criteria
Inclusion
- The patient was found to have a nasopharyngeal lesion through the nasopharyngeal endoscopy and the clinicans considered it necessary to perform an biopsy.
- Hemilateral lesion with limited size.
Exclusion
- Patients with nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, etc. who have already been treated.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 28 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05202626
Start Date
December 1 2021
End Date
June 28 2025
Last Update
October 17 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Provincial Cancer Hospital
Fuzhou, Fujian, China, 350014
2
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510060
3
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510060
4
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China, 510060